Evidence map›Paper›PMID 39279228›Full record

ArticleJournal of neuropathology and experimental neurology2025

Long survival in a patient with fumarate hydratase mutation-associated glioma.

Regina R Reimann, Dorothee Gramatzki, Andrea Bink, Jürgen Hench, Stephan Frank, Martina Haberecker, Tibor Hortobagyi, Kristof Egervari, Doron Merkler, Kenneth Aldape and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Regina R ReimannInstitute of Neuropathology, University Hospital and University of Zurich, Zurich, Switzerland.ORCID 0000-0002-6396-4195
Dorothee GramatzkiDepartment of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.ORCID 0000-0002-9054-5498
Andrea BinkDepartment of Neuroradiology, University Hospital Zurich, Zurich, Switzerland.
Jürgen HenchDivision of Neuropathology, Institute for Pathology, University Hospital Basel, Basel, Switzerland.ORCID 0000-0002-9884-1240
Stephan FrankDivision of Neuropathology, Institute for Pathology, University Hospital Basel, Basel, Switzerland.
Martina HabereckerInstitute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0001-5704-7721
Tibor HortobagyiInstitute of Neuropathology, University Hospital and University of Zurich, Zurich, Switzerland.ORCID 0000-0001-5732-7942
Kristof EgervariDivision of Clinical Pathology, Geneva University Hospital, Geneva, Switzerland.ORCID 0000-0001-6763-9069
Doron MerklerDivision of Clinical Pathology, Geneva University Hospital, Geneva, Switzerland.ORCID 0000-0002-0247-2007
Kenneth AldapeLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.ORCID 0000-0001-5119-7550
Michael WellerDepartment of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.ORCID 0000-0002-1748-174X

Funding

Filling the gap UZH
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39279228
PMCPMC12090989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.